Citation Impact
Citing Papers
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
2003 StandoutScience
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Breast cancer
2019 Standout
Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence
2007 Standout
Development and feasibility testing of decision support for patients who are candidates for a prophylactic implantable defibrillator: a study protocol for a pilot randomized controlled trial
2013
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Chipping Away the ‘Missing Heritability’: GIANT Steps Forward in the Molecular Elucidation of Obesity – but Still Lots to Go
2010
BRCA1 and BRCA2: 1994 and beyond
2004
Randomized Trial of a Decision Aid for Patients with Cystic Fibrosis Considering Lung Transplantation
2009
Clinical management of BRCA1 and BRCA2 mutation carriers
2006
Cancer Incidence in BRCA1 Mutation Carriers
2002
Updates on breast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer
2016
Tubal ligation and the risk of ovarian cancer: review and meta-analysis
2010
African ancestry and higher prevalence of triple‐negative breast cancer
2010
Cell-cycle checkpoints and cancer
2004 StandoutNature
BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer
2000
Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland
2005
Ovarian cancer
2014 Standout
Breast cancer: occurrence, risk factors and hormone metabolism
2003
Phaeochromocytoma
2005 Standout
Rethinking mechanisms, diagnosis and management of endometriosis
2019 Standout
Lifestyle-related factors and environmental agents causing cancer: An overview
2007 StandoutNobel
Epidemiology of Prostate Cancer
2019 Standout
ESHRE guideline: management of women with endometriosis
2014 Standout
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations
2007
Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing
2005
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
2007 Standout
Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer
2010
Molecular mechanisms of cisplatin resistance
2011 Standout
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
2010 Standout
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: Impact on measures of decision making and satisfaction.
2009
The DNA Damage Response: Making It Safe to Play with Knives
2010 Standout
Association Between CHEK2*1100delC and Breast Cancer: A Systematic Review and Meta-Analysis
2018
Bias in Intervention Studies That Enroll Patients From High-Risk Clinics
2004
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
2009 StandoutNature
Male breast cancer
2006 Standout
Modifiers of risk of hereditary breast and ovarian cancer
2002
Genomic imprinting and environment in hereditary paraganglioma
2004
Cancer risks among BRCA1 and BRCA2 mutation carriers
2007
On the Use of Familial Aggregation in Population-Based Case Probands for Calculating Penetrance
2002
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis
2011
Recent Advances in Breast Cancer Genetics
2007
Impact of Informing Overweight Individuals about the Role of Genetics in Obesity: An Online Experimental Study
2013 Standout
Wound dressings – a review
2015 Standout
Genomic instability — an evolving hallmark of cancer
2010 Standout
Polycystic ovary syndrome
2016 Standout
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
2010 Standout
Oral Contraceptive Use and Risk of Breast Cancer among Women with a Family History of Breast Cancer: a Prospective Cohort Study
2005
The cancer genome
2009 StandoutNature
Cancer of the Ovary
2004 Standout
Direct-to-patient BRCA1 testing: the Twoj Styl experience
2006
U.S. Medical Eligibility Criteria for Contraceptive Use, 2010
2011
The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
2001
Molecular Biology of the 3β-Hydroxysteroid Dehydrogenase/Δ5-Δ4 Isomerase Gene Family
2005
Change in the penetrance of founder BRCA1/2 mutations? A retrospective cohort study
2002
Oral Contraceptives and Risk of Ovarian Cancer and Breast Cancer Among High-Risk Women: A Systematic Review and Meta-Analysis
2013
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
2006 Standout
Hereditary gynaecological malignancies: advances in screening and treatment
2012
Ovarian cancer statistics, 2018
2018 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
2002
Preventing Future Cancers by Testing Women With Ovarian Cancer forBRCAMutations
2009
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
2016 Standout
Clinical Characteristics of Individuals With Germline Mutations in BRCA1 and BRCA2: Analysis of 10,000 Individuals
2002
Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control Study
2005 Standout
Fallopian Tube and Primary Peritoneal Carcinomas Associated With BRCA Mutations
2003
Screening for Founder Mutations in BRCA1 and BRCA2 in Unselected Jewish Women
2009
Selenium for preventing cancer
2018
Clinical Characteristics of Individuals With Germline Mutations in BRCA1 and BRCA2: Analysis of 10,000 Individuals
2002
Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations
2010 Standout
Hereditary Cancer Predisposition Syndromes
2005
DNA Repair Pathways in Clinical Practice: Lessons From Pediatric Cancer Susceptibility Syndromes
2006
Modifiers of Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Systematic Review and Meta-Analysis
2014
GermlineBRCAMutations Denote a Clinicopathologic Subset of Prostate Cancer
2010
Longitudinal Changes in Patient Distress following Interactive Decision Aid Use among BRCA1/2 Carriers
2010
Obesity: global epidemiology and pathogenesis
2019 Standout
Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
2005 Standout
Hereditary breast cancer
2001
Breast cancer statistics, 2013
2013 Standout
Works of SA Narod being referenced
Evaluation of the needs of spouses of female carriers of mutations in BRCA1 and BRCA2
2002
Oral Contraceptives and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
2002
Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation
2007
Estrogen receptor status in CHEK2‐positive breast cancers: implications for chemoprevention
2008
High risk genes predisposing to prostate cancer development—do they exist?
2000
Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer
1999
Selenium and the risk of cancer in BRCA1 carriers
2011
NBS1 Is a Prostate Cancer Susceptibility Gene
2004
Testing for CHEK2 in the cancer genetics clinic: ready for prime time?
2010